Publication date: Jul 17, 2019
Big data, coupled with the use of advanced analytical approaches, such as artificial intelligence (AI), have the potential to improve medical outcomes and population health. Data that are routinely generated from, for example, electronic medical records and smart devices have become progressively easier and cheaper to collect, process, and analyze. In recent decades, this has prompted a substantial increase in biomedical research efforts outside traditional clinical trial settings. Despite the apparent enthusiasm of researchers, funders, and the media, evidence is scarce for successful implementation of products, algorithms, and services arising that make a real difference to clinical care. This article collection provides concrete examples of how “big data” can be used to advance healthcare and discusses some of the limitations and challenges encountered with this type of research. It primarily focuses on real-world data, such as electronic medical records and genomic medicine, considers new developments in AI and digital health, and discusses ethical considerations and issues related to data sharing. Overall, we remain positive that big data studies and associated new technologies will continue to guide novel, exciting research that will ultimately improve healthcare and medicine-but we are also realistic that concerns remain about privacy, equity, security, and benefit to all.
Open Access PDF
Car, J., Sheikh, A., Wicks, P., and Williams. Beyond the hype of big data and artificial intelligence: building foundations for knowledge and wisdom. 06550. 2019 BMC Med (17):1.
|disease||MESH||alcoholic fatty liver|
- Systematic Review of Privacy-Preserving Distributed Machine Learning From Federated Databases in Health Care.
- EP#007: Privacy protection in the age of Personalized Medicine with Dr Rachele Hendriks-Sturrup
- Application of bioinformatics in support of precision medicine
- Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases.
- Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.